|Digirad Corporation -- USA Stock|| |
USD 2.3 0.05 2.13%
President CEO, Director
Mr. Matthew G. Molchan is President, Chief Executive Officer, Director of Digirad Corporationration He was appointed as Chief Executive Officer, Director of the Company on July 1, 2013. He was previously Chief Operating Officer of Digirad Ultrascan Solutions from May 2007 to January 2012. He joined Digirad Ultrascan Solutions upon the acquisition of Ultrascan, Inc. by Digirad Corporationrationration in May 2007. Prior to joining Digirad, Mr. Molchan was the CFO for Ultrascan, Inc the southeast mobile ultrasound business. Matt joined Ultrascan, Inc. in 2003. Prior to Ultrascan, Mr. Molchan held various executive level business development, finance and operations positions at Somera, Inc. and Equifax, Inc
Age: 43 CEO Since 2013
Molchan holds a BS degree in Economics from the United States Air Force Academy and a Masters of Business Administration in finance from the University of Southern California..
The company has return on total asset (ROA)
of 0.8 %
which means that it generated profit of $0.8 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (5.01) %
meaning that it created substantial loss on money invested by shareholders.
The company currently holds 20.01 M in liabilities with Debt to Equity (D/E) ratio of 33.0 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Digirad Corporation has Current Ratio of 1.28 suggesting that it is not liquid enough and may have problems to pay out its financial obligations when they are due.
Digirad Corporationration offer diagnostic solutions in the United States. Digirad Corporation (DRAD) is traded on NASDAQ General Markets in USA. It is located in GEORGIA, U.S.A and employs 323 people. Digirad is listed under Medical Equipment category by Fama And French industry classification.